Skip to main content
Equibles

MORGAN STANLEY

Position in SLGL — Sol-Gel Technologies Ltd.

CIK 895421 NEW YORK, NY
Back to SLGL Full portfolio

Position in SLGL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$341,562
-$68,084 QoQ
Shares Held
4,607
-10.9% QoQ
Ownership
0.141%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 24 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SLGL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. SLGL ranks #289 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in SLGL

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $341,562 4,607
2026-03-31 $409,646 5,171
2025-12-31 $197,383 4,684
2025-09-30 $127,239 4,365
2025-06-30 $39,479 5,335
2025-03-31 $48,027 92,360
2024-12-31 $82,062 88,239
2024-09-30 $22,684 33,360
2024-06-30 $58,569 65,809
2024-03-31 $37,811 38,584
2023-12-31 $31,972 28,935
2023-09-30 $47,652 29,235
2023-06-30 $98,343 32,891
2023-03-31 $116,147 29,935
2022-12-31 $135,135 29,635
2022-09-30 $167,853 33,437
2022-06-30 $151,433 36,935
2022-03-31 $248,225 33,635
2021-12-31 $255,559 34,535
2021-09-30 $358,350 35,835
2021-06-30 $469,634 37,935
2021-03-31 $517,124 41,771
2020-12-31 $419,364 42,836
2020-09-30 $343,870 47,496
2020-06-30 $342,263 38,229
2020-03-31 $123,105 17,437